These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25418676)

  • 1. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
    Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels.
    Torregrosa R; Yang XF; Dustrude ET; Cummins TR; Khanna R; Kohn H
    Bioorg Med Chem; 2015 Jul; 23(13):3655-66. PubMed ID: 25922183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-gated Sodium Channels and in the Treatment of Neuropathic Pain.
    Wang Y; Wilson SM; Brittain JM; Ripsch MS; Salomé C; Park KD; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2011 Jun; 2(6):317-322. PubMed ID: 21765969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
    Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C
    Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.
    Salomé C; Salomé-Grosjean E; Stables JP; Kohn H
    J Med Chem; 2010 May; 53(9):3756-71. PubMed ID: 20394379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons.
    Niespodziany I; André VM; Leclère N; Hanon E; Ghisdal P; Wolff C
    CNS Neurosci Ther; 2015 Mar; 21(3):241-51. PubMed ID: 25444522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HYP-17, a novel voltage-gated sodium channel blocker, relieves inflammatory and neuropathic pain in rats.
    Lee JY; Kam YL; Oh J; Kim DH; Choi JS; Choi HY; Han S; Youn I; Choo HP; Yune TY
    Pharmacol Biochem Behav; 2017 Feb; 153():116-129. PubMed ID: 28024908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats.
    Kam YL; Back SK; Kang B; Kim YY; Kim HJ; Rhim H; Nah SY; Chung JM; Kim DH; Choi JS; Na HS; Choo HY
    Pharmacol Biochem Behav; 2012 Nov; 103(1):33-42. PubMed ID: 22867799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
    Desaphy JF; Farinato A; Altamura C; De Bellis M; Imbrici P; Tarantino N; Caccia C; Melloni E; Padoani G; Vailati S; Keywood C; Carratù MR; De Luca A; Conte D; Pierno S
    Exp Neurol; 2020 Jun; 328():113287. PubMed ID: 32205118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
    Errington AC; Stöhr T; Heers C; Lees G
    Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties.
    Park KD; Yang XF; Lee H; Dustrude ET; Wang Y; Khanna R; Kohn H
    ACS Chem Neurosci; 2013 Mar; 4(3):463-74. PubMed ID: 23509982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of in vitro and in vivo high glucose-induced alterations in voltage-gated tetrodotoxin-resistant sodium channel: Effects attenuated by sodium channel blockers.
    Kharatmal SB; Singh JN; Sharma SS
    Neuroscience; 2015 Oct; 305():183-96. PubMed ID: 26255676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
    Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.
    Hagenacker T; Schäfer N; Büsselberg D; Schäfers M
    Eur J Pain; 2013 Jul; 17(6):881-92. PubMed ID: 23229998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory actions by lacosamide, a functionalized amino acid, on voltage-gated Na+ currents.
    Huang CW; Hung TY; Wu SN
    Neuroscience; 2015 Feb; 287():125-36. PubMed ID: 25534720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities.
    King AM; Salomé C; Dinsmore J; Salomé-Grosjean E; De Ryck M; Kaminski R; Valade A; Kohn H
    J Med Chem; 2011 Jul; 54(13):4815-30. PubMed ID: 21639114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol metabolite cholestane-3β,5α,6β-triol suppresses epileptic seizures by negative modulation of voltage-gated sodium channels.
    Tang L; Wang Y; Leng T; Sun H; Zhou Y; Zhu W; Qiu P; Zhang J; Lu B; Yan M; Chen W; Su X; Yin W; Huang Y; Hu H; Yan G
    Steroids; 2015 Jun; 98():166-72. PubMed ID: 25578735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
    Sheets PL; Heers C; Stoehr T; Cummins TR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.